Pharma Synth Formulations Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 1993.
1993 Delhi, Delhi, India Active
Last Updated:
Access Report
About Pharma Synth Formulations Limited

Pharma Synth Formulations Limited, a active public limited company, was established on 26 November 1993 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1993PLC056231. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Employing 223 professional, Its leadership includes Phoolwati Jain (Director), Ramesh Chand Jain (Director), Arvind Kumar Gupta (Director). It holds ₹18.00 Cr open charges and ₹24.03 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 10/15Jhilmil Industrial Area, Delhi, Delhi, 110095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1993PLC056231

  • Registration Number

    056231

  • Incorporation Date

    26 November 1993

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 32 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 18.00 Cr
  • Satisfied Charges ₹ 24.03 Cr
  • Revenue Growth **** 0.75%
  • Profit Growth **** 25.43%
  • Ebitda **** -1.17%
  • Net Worth 11.97%
  • Total Assets **** 15.77%
Company report

Pharma Synth Formulations Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharma Synth Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Pharma Synth Formulations Limited?
Current Directors
Name Designation Appointment Date Status
Phoolwati Jain Director 08 Mar 1994 Current
Ramesh Chand Jain Director 26 Nov 1993 Current
Arvind Kumar Gupta Director 26 Nov 1993 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharma Synth Formulations.

Pharma Synth Formulations Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.75% increase. The company also saw a substantial improvement in profitability, with a 25.43% increase in profit. The company's net worth Soared by an impressive increase of 11.97%.

Pharma Synth Formulations revenue growth over time
Pharma Synth Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -3.53%
*******
*******
*******
*******
Total Assets
*******
 15.77%
*******
*******
*******
*******
Profit or Loss
*******
 25.43%
*******
*******
*******
*******
Net Worth
*******
 11.97%
*******
*******
*******
*******
EBITDA
*******
 -1.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharma Synth Formulations?

In 2024, Pharma Synth Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹180,000,000.00

Satisfied Charges

₹240,322,000.00

Charges Breakdown by Lending Institutions
  • Sidbi : 18.00 Cr
Latest Charge Details
Date Lender Amount Status
13 Sep 2024 Sidbi ₹8.00 Cr Open
13 Sep 2024 Sidbi ₹8.00 Cr Open
13 Sep 2024 Sidbi ₹2.00 Cr Open
20 Jan 2023 Sidbi ₹16.00 Cr Satisfied
28 Mar 2022 Sidbi ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Pharma Synth Formulations?

Pharma Synth Formulations has a workforce of 223 employees as of Mar 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharma Synth Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Synth Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharma Synth Formulations
Recent Activity within the Organization
  • Annual General Meeting

    The activity Pharma Synth Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    The activity A charge registered on 20 Jan 2023 via Charge ID 100674524 with Sidbi was fully satisfied on 24 Sep 2024. was completed.

  • Charges

    Progress on A charge registered on 28 Mar 2022 via Charge ID 100551116 with Sidbi was fully satisfied on 24 Sep 2024. was documented.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 80.00 M with Charge ID 100979051 was registered on 13 Sep 2024. was documented.

  • Charges

    A charge with Sidbi amounted to Rs. 80.00 M with Charge ID 100979003 was registered on 13 Sep 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100978996 was registered on 13 Sep 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharma Synth Formulations Limited?

The CIN of Pharma Synth Formulations Limited is U74899DL1993PLC056231.

Where is Pharma Synth Formulations Limited headquartered?

Pharma Synth Formulations Limited is headquartered at A - 10/15Jhilmil Industrial Area, Delhi, Delhi, 110095.

When was Pharma Synth Formulations Limited incorporated?

Pharma Synth Formulations Limited was incorporated on 26 November 1993.

Who are the current directors of Pharma Synth Formulations Limited?

The current directors of Pharma Synth Formulations Limited are

What is the primary industry of Pharma Synth Formulations Limited?

The primary industry of Pharma Synth Formulations Limited is Manufacturing.

Is Pharma Synth Formulations Limited a listed company?

Pharma Synth Formulations Limited is unlisted.

What is the capital structure of Pharma Synth Formulations Limited?

The authorized capital of Pharma Synth Formulations Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Pharma Synth Formulations Limited?

The compliance status of Pharma Synth Formulations Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available